Anzeige
Mehr »
Login
Mittwoch, 25.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Während die Wall Street über Krypto-ETFs debattiert, liefert dieses Unternehmen 1.000?% RENDITE!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

AFX News-Archiv vom 21.12.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
SaEHang And Chongqing Changan Automobile Partner On Flying Car Innovations769BEIJING (dpa-AFX) - EHang Holdings Limited (EH), Urban Air Mobility technology platform company, said Saturday that it signed a strategic cooperation agreement with Chongqing Changan Automobile...
► Artikel lesen
SaKnorr-Bremse Sells R.H. Sheppard To Balmoral727BERLIN (dpa-AFX) - Knorr-Bremse AG (KNRRY.PK), a German manufacturer of braking systems, announced the sale of R.H. Sheppard Co., Inc. to the US investor Balmoral RHS Acquisition Corp. Sheppard...
► Artikel lesen
SaQualcomm Wins Jury Verdict Upholding Innovation And ARM Contract796SAN DIEGO (dpa-AFX) - Qualcomm (QCOM) expressed satisfaction with today's decision, stating that the jury has validated Qualcomm's right to innovate. The verdict affirms that all Qualcomm products...
► Artikel lesen
SaVolkswagen And Union Agree To Job Cuts Of Over 35,000 By 2030653WOLFSBURG (dpa-AFX) - Volkswagen Group (VKW.L, VLKAF.PK, VOW.BE) and its union have agreed on a socially responsible reduction in the workforce of more than 35,000 across the company's German...
► Artikel lesen
SaFDA Grants Accelerated Approval To Pfizer's BRAFTOVI Combination For Metastatic Colorectal Cancer840NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said that the U.S. Food and Drug Administration has approved BRAFTOVI (encorafenib) in combination with cetuximab (marketed as ERBITUX) and mFOLFOX6...
► Artikel lesen
SaFDA Approves Lilly's Zepbound To Treat Obstructive Sleep Apnea In Adults With Obesity672INDIANAPOLIS (dpa-AFX) - The U.S. Food and Drug Administration approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea or OSA in adults with obesity,...
► Artikel lesen